GE HealthCare Technologies Inc.
For the period ended Sep 30, 2026. Filed Oct 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 28, 2026
GEHC$84.03+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Equity
| Condensed Consolidated Statements of Changes in Equity (Unaudited) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock | |||||||||
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of June 30, 2026 | 459 | $5 | 8 | $(525) | $6,776 | $6,199 | $(1,480) | $14 | $10,989 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | — | — | — | — | (14) | — | — | — | (14) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 615 | — | — | 615 |
| Dividends declared ($0.04 per common share) | — | — | — | — | — | (18) | — | — | (18) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | 21 | — | 21 |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 2 | 2 |
| Share-based compensation | — | — | — | — | 35 | — | — | — | 35 |
| Balances as of September 30, 2026 | 460 | $5 | 8 | $(525) | $6,797 | $6,795 | $(1,459) | $17 | $11,630 |
| Common stock · Treasury stock | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of June 30, 2025 | 458 | $5 | 2 | $(125) | $6,628 | $4,295 | $(1,090) | $21 | $9,733 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | — | — | — | — | (4) | — | — | — | (4) |
| Repurchase of common stock | — | — | 1 | (100) | — | — | — | — | (100) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 446 | — | — | 446 |
| Dividends declared ($0.07 per common share) | — | — | — | — | — | (32) | — | — | (32) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | (66) | — | (66) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 2 | 2 |
| Share-based compensation | — | — | — | — | 37 | — | — | — | 37 |
| Balances as of September 30, 2025 | 459 | $5 | 3 | $(225) | $6,661 | $4,709 | $(1,156) | $23 | $10,016 |
| Condensed Consolidated Statements of Changes in Equity (Unaudited) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock | |||||||||
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2025 | 459 | $5 | 3 | $(225) | $6,707 | $5,281 | $(1,388) | $11 | $10,390 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 1 | — | — | — | (24) | — | — | — | (24) |
| Repurchase of common stock | — | — | 5 | (300) | — | — | — | — | (300) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,564 | — | — | 1,564 |
| Dividends declared ($0.11 per common share) | — | — | — | — | — | (50) | — | — | (50) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | (71) | — | (71) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 6 | 6 |
| Share-based compensation | — | — | — | — | 115 | — | — | — | 115 |
| Balances as of September 30, 2026 | 460 | $5 | 8 | $(525) | $6,797 | $6,795 | $(1,459) | $17 | $11,630 |
| Common stock · Treasury stock | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2024 | 457 | $5 | — | $(25) | $6,583 | $3,262 | $(1,379) | $18 | $8,464 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 1 | — | — | — | (16) | — | — | — | (16) |
| Repurchase of common stock | — | — | 3 | (200) | — | — | — | — | (200) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,495 | — | — | 1,495 |
| Dividends declared ($0.105 per common share) | — | — | — | — | — | (48) | — | — | (48) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | 223 | — | 223 |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 4 | 4 |
| Share-based compensation | — | — | — | — | 93 | — | — | — | 93 |
| Balances as of September 30, 2025 | 459 | $5 | 3 | $(225) | $6,661 | $4,709 | $(1,156) | $23 | $10,016 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.